SCHEMBL2768381

SCHEMBL2768381

COc1cc(F)c(N2CCC(Cc3ccccc3)CC2)cc1F

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 1/20 0.55
SLC6A4 P31645 1/20 0.55
FFAR4 Q5NUL3 1/20 0.52
ABCB1 P08183 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPK14 Q16539 1/20 0.49
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
SIGMAR1 Q99720 2/20 0.47
HTR1A P08908 1/20 0.47
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
HTT P42858 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2767116 0.86 FFAR4 (0.48) SLC6A2SLC6A4FFAR4ABCB1HTR1A
SCHEMBL2767466 0.81 FFAR4 (0.46) SLC6A2SLC6A4FFAR4KMT2AALDH1A1
SCHEMBL2767469 0.81 FFAR4 (0.46) SLC6A2SLC6A4FFAR4KMT2AALDH1A1
SCHEMBL2768139 0.81 MAPT (0.50) SLC6A2SLC6A4CYP2C9CYP2C19MAPK14
SCHEMBL2766148 0.78 ADRA1D (0.68) SIGMAR1HTR1A
SCHEMBL7242753 0.78 SLC6A2 (0.58) SLC6A2SLC6A4ABCB1CYP2C9CYP2C19
SCHEMBL2766664 0.76 FFAR4 (0.50) FFAR4ALDH1A1LMNARAB9ASMN1; SMN2
SCHEMBL7240022 0.75 SLC6A2 (0.55) SLC6A2SLC6A4ABCB1CYP2C9CYP2C19
SCHEMBL2766487 0.74 FFAR4 (0.59) FFAR4CYP2C19KMT2AALDH1A1
SCHEMBL7240028 0.73 SLC6A2 (0.61) SLC6A2SLC6A4ABCB1CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627871-B1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE ASKA PHARM CO LTD (JP) 2010-04-14 EP disclosed
US-7449466-B2 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2008-11-11 US disclosed
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative ASKA PHARMACEUTICAL CO., LTD. (JP) 2006-08-24 US disclosed
EP-1627871-A1 CYCLIC AMINOPHENYL SULFAMATE DERIVATIVE Teikoku Hormone Mfg. Co., Ltd. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060189625-A1 Cyclic aminophenyl sulfamate derivative SHBG, STS, ARSA SLC6A2 1829/4885SLC6A4 1148/4885FFAR4 2828/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.